{'fraction_non_alphanumeric': 0.020868113522537562, 'fraction_numerical': 0.0008347245409015025, 'mean_word_length': 5.310526315789474, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
[Role of nitric oxic in pregnancy and pre-eclampsia].

The mechanisms involved in the physiology of pregnancy and in the pathophysiology of preeclampsia are still largely unknown. Prostaglandins metabolism, especially an imbalance between thromboxane A2 and prostacyclin does not appear sufficient to explain all the observed changes. Recent studies have shown that nitric oxide (NO), a vasodilating and a platelet anti-aggregating factor, could play a pivotal role in inducing hemodynamic changes during pregnancy. NO is produced in excess during pregnancy, mainly in uterine and renal vascular beds. Similarly, NO is in part responsible for the non-responsiveness of the vessels to vasoactive agents and plays a relevant role in peripheral vasodilation and in lowering systemic blood pressure. Furthermore, NO improves blood supply to the fetal-placental unit and to maternal kidneys. An impaired NO metabolism in pregnant rats induces changes similar to those observed in human preeclampsia. NO pathway represents a new approach to the physiology of pregnancy and to the pathophysiology of preeclampsia. Moreover, NO donors might be carefully proposed as new therapeutic agents in this disorder.